{"schema_version":"secwatch.filing_event.v1","accession":"0001703057-24-000024","form_type":"8-K","ticker":"ABCL","cik":"0001703057","company_name":"AbCellera Biologics Inc.","filed_at":"2024-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.173675+00:00","generated_at":"2026-06-05T17:12:10.758218+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"AbCellera board member Peter Thiel resigns effective March 7, 2024","bullets":["Peter Thiel resigns from AbCellera board for personal reasons; no disagreement with company.","Board size reduced from six to five directors effective March 7, 2024.","Dr. Andrew Lo appointed to Nominating and Corporate Governance Committee replacing Thiel."],"urls":{"canonical":"https://secwatch.observer/filing/0001703057-24-000024","json":"https://secwatch.observer/filing/0001703057-24-000024.json","markdown":"https://secwatch.observer/filing/0001703057-24-000024.md","text":"https://secwatch.observer/filing/0001703057-24-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000024/0001703057-24-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000024/abcl-20240216.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T17:12:10.758218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"563bd50667","claim":"Peter Thiel retired as Director at AbCellera Biologics Inc..","evidence_excerpt":"On February 16, 2024, Peter Thiel, a member of the Board of Directors of AbCellera Biologics Inc. (the “Company”) and the Chairman of the Nominating and Corporate Governance Committee thereof, notified the Company of his intention to retire from the Company’s Board of Directors and all committees for personal reasons, effective March 7, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000024/0001703057-24-000024-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}